Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic
B. Seeliger (Hannover, Germany), K. Stahl (Hannover, Germany), M. Busch (Hannover, Germany), O. Wiesner (Hannover, Germany), T. Welte (Hannover, Germany), M. Hoeper (Hannover, Germany), M. Eder (Hannover, Germany), A. Heim (Hannover, Germany), S. David (Hannover, Germany)
Source: International Congress 2019 – Clinical challenges in respiratory infection
Session: Clinical challenges in respiratory infection
Session type: Thematic Poster
Number: 4561
Disease area: Respiratory critical care, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Seeliger (Hannover, Germany), K. Stahl (Hannover, Germany), M. Busch (Hannover, Germany), O. Wiesner (Hannover, Germany), T. Welte (Hannover, Germany), M. Hoeper (Hannover, Germany), M. Eder (Hannover, Germany), A. Heim (Hannover, Germany), S. David (Hannover, Germany). Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic. 4561
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: